Abstract
The ACL presents a large spectrum of manifestation, varying from asymptomatic and/or sub clinical in resistant individuals till different forms in susceptible individuals, such as localized cutaneous Leishmaniasis (LCL), borderline disseminated cutaneous Leishmaniasis (BDCL), mucocutaneous leishmaniasis (MCL), mucosal leishmaniasis (ML) and anergic diffuse cutaneous leishmaniasis (ADCL), …